JP2013520960A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520960A5
JP2013520960A5 JP2012540193A JP2012540193A JP2013520960A5 JP 2013520960 A5 JP2013520960 A5 JP 2013520960A5 JP 2012540193 A JP2012540193 A JP 2012540193A JP 2012540193 A JP2012540193 A JP 2012540193A JP 2013520960 A5 JP2013520960 A5 JP 2013520960A5
Authority
JP
Japan
Prior art keywords
protein
amount
cell
human subject
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012540193A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520960A (ja
JP5846608B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/055570 external-priority patent/WO2011108766A1/en
Publication of JP2013520960A publication Critical patent/JP2013520960A/ja
Publication of JP2013520960A5 publication Critical patent/JP2013520960A5/ja
Application granted granted Critical
Publication of JP5846608B2 publication Critical patent/JP5846608B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012540193A 2010-03-03 2011-03-03 ｉＰＳ細胞由来の神経細胞を用いた蛋白質ミスフォールディング病の診断方法 Expired - Fee Related JP5846608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30992710P 2010-03-03 2010-03-03
US61/309,927 2010-03-03
PCT/JP2011/055570 WO2011108766A1 (en) 2010-03-03 2011-03-03 METHOD FOR DIAGNOSING A PROTEIN MISFOLDING DISEASE USING NERVE CELLS DERIVED FROM iPS CELLS

Publications (3)

Publication Number Publication Date
JP2013520960A JP2013520960A (ja) 2013-06-10
JP2013520960A5 true JP2013520960A5 (enExample) 2014-06-26
JP5846608B2 JP5846608B2 (ja) 2016-01-20

Family

ID=44542394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540193A Expired - Fee Related JP5846608B2 (ja) 2010-03-03 2011-03-03 ｉＰＳ細胞由来の神経細胞を用いた蛋白質ミスフォールディング病の診断方法

Country Status (3)

Country Link
US (1) US9097727B2 (enExample)
JP (1) JP5846608B2 (enExample)
WO (1) WO2011108766A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
AU2011258634B2 (en) * 2010-05-25 2015-03-26 Memorial Sloan-Kettering Cancer Center Method of nociceptor differentiation of human embryonic stem cells and uses thereof
CN113528442A (zh) 2011-11-04 2021-10-22 纪念斯隆-凯特琳癌症中心 用于植入的中脑多巴胺（da）神经元
WO2013140927A1 (ja) * 2012-03-21 2013-09-26 国立大学法人京都大学 アルツハイマー病の治療薬および/または予防薬のスクリーニング方法
EP3498824A1 (en) 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
US20160030484A1 (en) * 2014-08-04 2016-02-04 University Of Kansas Mammalian pluripotent stem cells, methods for their production, and uses thereof
JP7420334B2 (ja) 2015-06-25 2024-01-23 株式会社カネカ 液体注入方法
US20210123025A1 (en) * 2018-07-03 2021-04-29 Universidad Del País Vasco - Euskal Herriko Unibertsitatea Cellular aggregates for use in vascularisation therapy
WO2020165615A1 (en) 2019-02-14 2020-08-20 Omnion Research International D.O.O. Method of transformation of hair folicle cells into neurons, method and scale for estimating risk for onset of a particular brain disease
JP7333579B2 (ja) * 2019-05-08 2023-08-25 国立大学法人東京工業大学 アルツハイマー疾患モデル神経細胞及びその製造方法、並びにその神経細胞を用いたアルツハイマー病作用薬物のスクリーニング方法
US12412266B2 (en) 2019-05-31 2025-09-09 Kyoto University Information processing device, screening device, information processing method, screening method, and program
EP3978595A4 (en) 2019-05-31 2023-07-05 Kyoto University INFORMATION PROCESSING DEVICE, SCREENING DEVICE, INFORMATION PROCESSING METHOD, SCREENING METHOD AND PROGRAM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003235113A1 (en) 2002-04-26 2003-11-10 Riken Method of measuring neprilysin activity
ZA200401646B (en) * 2003-03-12 2004-06-07 Reliance Life Sciences Pvt Ltd Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.
BRPI0408733A (pt) * 2003-03-12 2006-03-07 Reliance Life Sciences Pvt Ltd derivação de neurÈnios dopaminérgicos terminalmente diferenciados de células tronco embriÈnicas humanas
WO2010008486A2 (en) 2008-06-24 2010-01-21 Parkinsons Institute Pluripotent cell lines and methods of use thereof

Similar Documents

Publication Publication Date Title
Frontzkowski et al. Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Onos et al. Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation
Mander et al. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease?
Gaiteri et al. Genetic variants in Alzheimer disease—molecular and brain network approaches
Cushing et al. Impaired hippocampal-cortical interactions during sleep in a mouse model of Alzheimer’s disease
Moya-Alvarado et al. Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?
Naudí et al. Lipidomics of human brain aging and Alzheimer's disease pathology
Liu et al. Olfactory deficit: a potential functional marker across the Alzheimer’s disease continuum
Gómez-Sintes et al. Mice with a naturally occurring DISC1 mutation display a broad spectrum of behaviors associated to psychiatric disorders
EA201590175A1 (ru) Скрининг, диагностика и прогнозирование аутизма и других нарушений развития
El Alaoui et al. Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive–behavioural therapy for social anxiety disorder in routine psychiatric care
Ogonowski et al. Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis
Jarek et al. Evaluating p-tau217 and p-tau231 as biomarkers for early diagnosis and differentiation of Alzheimer’s disease: a narrative review
Mohamet et al. Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology
TW201606304A (zh) 測定治療反應之方法
Qiu et al. Alzheimer's disease progression model based on integrated biomarkers and clinical measures
Faisal et al. Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice
Vandenberghe The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia
Baxter et al. Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Kuang et al. Default mode network analysis of APOE genotype in cognitively unimpaired subjects based on persistent homology
Castillo-Mariqueo et al. Translational modeling of psychomotor function in normal and AD-pathological aging with special concerns on the effects of social isolation
Striebel et al. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice
Jiao et al. Temporal dynamics and composition of ocular surface microbiota in C57BL/6J mice: uncovering a 12h ultradian rhythm
Dehkordi et al. Identification of markers for neurescence through transcriptomic profiling of postmortem human brains
Danter Tracing Alzheimer’s genetic footprints: a pioneering longitudinal study using artificial intelligence to unravel mutation-driven risks and progression in virtual patients; part 1–the APOE genotypes